Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 25 entries
Sorted by: Best Match Show Resources per page
Response: human brain receptor distribution.

Science (New York, N.Y.)

Wong DF, Wagner HN, Dannals RF, Links JM, Kuhar MJ, Gjedde A.
PMID: 17810746
Science. 1986 Jun 06;232(4755):1270-1. doi: 10.1126/science.232.4755.1270.

No abstract available.

Cite
Wong DF, Wagner HN, Dannals RF, et al. Response: human brain receptor distribution. Science. 1986;232(4755):1270-1doi: 10.1126/science.232.4755.1270.
Wong, D. F., Wagner, H. N., Dannals, R. F., Links, J. M., Kuhar, M. J., & Gjedde, A. (1986). Response: human brain receptor distribution. Science (New York, N.Y.), 232(4755), 1270-1. https://doi.org/10.1126/science.232.4755.1270
Wong, D F, et al. "Response: human brain receptor distribution." Science (New York, N.Y.) vol. 232,4755 (1986): 1270-1. doi: https://doi.org/10.1126/science.232.4755.1270
Wong DF, Wagner HN, Dannals RF, Links JM, Kuhar MJ, Gjedde A. Response: human brain receptor distribution. Science. 1986 Jun 06;232(4755):1270-1. doi: 10.1126/science.232.4755.1270. PMID: 17810746.
Copy Download .nbib Format: NLM
Integration of ozone, UV/H.

The Science of the total environment

Granzoto MR, Seabra I, Malvestiti JA, Cristale J, Dantas RF.
PMID: 33218803
Sci Total Environ. 2021 Mar 10;759:143498. doi: 10.1016/j.scitotenv.2020.143498. Epub 2020 Nov 11.

Current studies tend to combine different advanced treatment technologies to reduce costs and increase efficiency. The objective of this work was to assess the combination of ozonation and UV/H

Cite
Granzoto MR, Seabra I, Malvestiti JA, et al. Integration of ozone, UV/H. Sci Total Environ. 2020;759:143498doi: 10.1016/j.scitotenv.2020.143498.
Granzoto, M. R., Seabra, I., Malvestiti, J. A., Cristale, J., & Dantas, R. F. (2021). Integration of ozone, UV/H. The Science of the total environment, 759143498. https://doi.org/10.1016/j.scitotenv.2020.143498
Granzoto, Mariana R, et al. "Integration of ozone, UV/H." The Science of the total environment vol. 759 (2021): 143498. doi: https://doi.org/10.1016/j.scitotenv.2020.143498
Granzoto MR, Seabra I, Malvestiti JA, Cristale J, Dantas RF. Integration of ozone, UV/H. Sci Total Environ. 2021 Mar 10;759:143498. doi: 10.1016/j.scitotenv.2020.143498. Epub 2020 Nov 11. PMID: 33218803.
Copy Download .nbib Format: NLM
The dynamics of gender and alternatives in negotiation.

The Journal of applied psychology

Dannals JE, Zlatev JJ, Halevy N, Neale MA.
PMID: 33411548
J Appl Psychol. 2021 Nov;106(11):1655-1672. doi: 10.1037/apl0000867. Epub 2021 Jan 07.

A substantial body of prior research documents a gender gap in negotiation performance. Competing accounts suggest that the gap is due either to women's stereotype-congruent behavior in negotiations or to backlash enacted toward women for stereotype-incongruent behavior. In this...

Cite
Dannals JE, Zlatev JJ, Halevy N, et al. The dynamics of gender and alternatives in negotiation. J Appl Psychol. 2021;106(11):1655-1672doi: 10.1037/apl0000867.
Dannals, J. E., Zlatev, J. J., Halevy, N., & Neale, M. A. (2021). The dynamics of gender and alternatives in negotiation. The Journal of applied psychology, 106(11), 1655-1672. https://doi.org/10.1037/apl0000867
Dannals, Jennifer E, et al. "The dynamics of gender and alternatives in negotiation." The Journal of applied psychology vol. 106,11 (2021): 1655-1672. doi: https://doi.org/10.1037/apl0000867
Dannals JE, Zlatev JJ, Halevy N, Neale MA. The dynamics of gender and alternatives in negotiation. J Appl Psychol. 2021 Nov;106(11):1655-1672. doi: 10.1037/apl0000867. Epub 2021 Jan 07. PMID: 33411548.
Copy Download .nbib Format: NLM
(Phenylamino)pyrimidine-1,2,3-triazole derivatives as analogs of imatinib: searching for novel compounds against chronic myeloid leukemia.

Beilstein journal of organic chemistry

Pimentel LCF, Hoelz LVB, Canzian HF, Branco FSC, de Oliveira AP, Campos VR, Júnior FPS, Dantas RF, Resende JALC, Cunha AC, Boechat N, Bastos MM.
PMID: 34621389
Beilstein J Org Chem. 2021 Sep 01;17:2260-2269. doi: 10.3762/bjoc.17.144. eCollection 2021.

The enzyme tyrosine kinase BCR-Abl-1 is the main molecular target in the treatment of chronic myeloid leukemia and can be competitively inhibited by tyrosine kinase inhibitors such as imatinib. New potential competitive inhibitors were synthesized using the (phenylamino)pyrimidine-pyridine (PAPP)...

Cite
Pimentel LCF, Hoelz LVB, Canzian HF, et al. (Phenylamino)pyrimidine-1,2,3-triazole derivatives as analogs of imatinib: searching for novel compounds against chronic myeloid leukemia. Beilstein J Org Chem. 2021;17:2260-2269doi: 10.3762/bjoc.17.144.
Pimentel, L. C. F., Hoelz, L. V. B., Canzian, H. F., Branco, F. S. C., de Oliveira, A. P., Campos, V. R., Júnior, F. P. S., Dantas, R. F., Resende, J. A. L. C., Cunha, A. C., Boechat, N., & Bastos, M. M. (2021). (Phenylamino)pyrimidine-1,2,3-triazole derivatives as analogs of imatinib: searching for novel compounds against chronic myeloid leukemia. Beilstein journal of organic chemistry, 172260-2269. https://doi.org/10.3762/bjoc.17.144
Pimentel, Luiz Claudio Ferreira, et al. "(Phenylamino)pyrimidine-1,2,3-triazole derivatives as analogs of imatinib: searching for novel compounds against chronic myeloid leukemia." Beilstein journal of organic chemistry vol. 17 (2021): 2260-2269. doi: https://doi.org/10.3762/bjoc.17.144
Pimentel LCF, Hoelz LVB, Canzian HF, Branco FSC, de Oliveira AP, Campos VR, Júnior FPS, Dantas RF, Resende JALC, Cunha AC, Boechat N, Bastos MM. (Phenylamino)pyrimidine-1,2,3-triazole derivatives as analogs of imatinib: searching for novel compounds against chronic myeloid leukemia. Beilstein J Org Chem. 2021 Sep 01;17:2260-2269. doi: 10.3762/bjoc.17.144. eCollection 2021. PMID: 34621389; PMCID: PMC8450943.
Copy Download .nbib Format: NLM
Tau pathology in cognitively normal older adults.

Alzheimer's & dementia (Amsterdam, Netherlands)

Ziontz J, Bilgel M, Shafer AT, Moghekar A, Elkins W, Helphrey J, Gomez G, June D, McDonald MA, Dannals RF, Azad BB, Ferrucci L, Wong DF, Resnick SM.
PMID: 31517026
Alzheimers Dement (Amst). 2019 Sep 06;11:637-645. doi: 10.1016/j.dadm.2019.07.007. eCollection 2019 Dec.

INTRODUCTION: Tau pathology, a hallmark of Alzheimer's disease, is observed in the brains of virtually all individuals over 70 years.METHODS: Using RESULTS: Greater age, male sex, black race, and amyloid positivity were associated with higher DISCUSSION: Assessment of medial...

Cite
Ziontz J, Bilgel M, Shafer AT, et al. Tau pathology in cognitively normal older adults. Alzheimers Dement (Amst). 2019;11:637-645doi: 10.1016/j.dadm.2019.07.007.
Ziontz, J., Bilgel, M., Shafer, A. T., Moghekar, A., Elkins, W., Helphrey, J., Gomez, G., June, D., McDonald, M. A., Dannals, R. F., Azad, B. B., Ferrucci, L., Wong, D. F., & Resnick, S. M. (2019). Tau pathology in cognitively normal older adults. Alzheimer's & dementia (Amsterdam, Netherlands), 11637-645. https://doi.org/10.1016/j.dadm.2019.07.007
Ziontz, Jacob, et al. "Tau pathology in cognitively normal older adults." Alzheimer's & dementia (Amsterdam, Netherlands) vol. 11 (2019): 637-645. doi: https://doi.org/10.1016/j.dadm.2019.07.007
Ziontz J, Bilgel M, Shafer AT, Moghekar A, Elkins W, Helphrey J, Gomez G, June D, McDonald MA, Dannals RF, Azad BB, Ferrucci L, Wong DF, Resnick SM. Tau pathology in cognitively normal older adults. Alzheimers Dement (Amst). 2019 Sep 06;11:637-645. doi: 10.1016/j.dadm.2019.07.007. eCollection 2019 Dec. PMID: 31517026; PMCID: PMC6732758.
Copy Download .nbib Format: NLM
Synthesis of new lophine-carbohydrate hybrids as cholinesterase inhibitors: cytotoxicity evaluation and molecular modeling.

MedChemComm

Lopes JPB, Silva L, Ceschi MA, Lüdtke DS, Zimmer AR, Ruaro TC, Dantas RF, de Salles CMC, Silva-Jr FP, Senger MR, Barbosa G, Lima LM, Guedes IA, Dardenne LE.
PMID: 32904099
Medchemcomm. 2019 Nov 08;10(12):2089-2101. doi: 10.1039/c9md00358d. eCollection 2019 Dec 01.

In this study, we synthesized nine novel hybrids derived from d-xylose, d-ribose, and d-galactose sugars connected by a methylene chain with lophine. The compounds were synthesized by a four-component reaction to afford the substituted imidazole moiety, followed by the...

Cite
Lopes JPB, Silva L, Ceschi MA, et al. Synthesis of new lophine-carbohydrate hybrids as cholinesterase inhibitors: cytotoxicity evaluation and molecular modeling. Medchemcomm. 2019;10(12):2089-2101doi: 10.1039/c9md00358d.
Lopes, J. P. B., Silva, L., Ceschi, M. A., Lüdtke, D. S., Zimmer, A. R., Ruaro, T. C., Dantas, R. F., de Salles, C. M. C., Silva-Jr, F. P., Senger, M. R., Barbosa, G., Lima, L. M., Guedes, I. A., & Dardenne, L. E. (2019). Synthesis of new lophine-carbohydrate hybrids as cholinesterase inhibitors: cytotoxicity evaluation and molecular modeling. MedChemComm, 10(12), 2089-2101. https://doi.org/10.1039/c9md00358d
Lopes, João Paulo Bizarro, et al. "Synthesis of new lophine-carbohydrate hybrids as cholinesterase inhibitors: cytotoxicity evaluation and molecular modeling." MedChemComm vol. 10,12 (2019): 2089-2101. doi: https://doi.org/10.1039/c9md00358d
Lopes JPB, Silva L, Ceschi MA, Lüdtke DS, Zimmer AR, Ruaro TC, Dantas RF, de Salles CMC, Silva-Jr FP, Senger MR, Barbosa G, Lima LM, Guedes IA, Dardenne LE. Synthesis of new lophine-carbohydrate hybrids as cholinesterase inhibitors: cytotoxicity evaluation and molecular modeling. Medchemcomm. 2019 Nov 08;10(12):2089-2101. doi: 10.1039/c9md00358d. eCollection 2019 Dec 01. PMID: 32904099; PMCID: PMC7451069.
Copy Download .nbib Format: NLM
In reply: elevated d2 dopamine receptors in drug-naive schizophrenics.

Science (New York, N.Y.)

Wong DF, Gjedde A, Wagner HM, Dannals RF, Links JM, Tune LE, Pearlson GD.
PMID: 17832943
Science. 1988 Feb 12;239(4841):790-1. doi: 10.1126/science.239.4841.790.

No abstract available.

Cite
Wong DF, Gjedde A, Wagner HM, et al. In reply: elevated d2 dopamine receptors in drug-naive schizophrenics. Science. 1988;239(4841):790-1doi: 10.1126/science.239.4841.790.
Wong, D. F., Gjedde, A., Wagner, H. M., Dannals, R. F., Links, J. M., Tune, L. E., & Pearlson, G. D. (1988). In reply: elevated d2 dopamine receptors in drug-naive schizophrenics. Science (New York, N.Y.), 239(4841), 790-1. https://doi.org/10.1126/science.239.4841.790
Wong, D F, et al. "In reply: elevated d2 dopamine receptors in drug-naive schizophrenics." Science (New York, N.Y.) vol. 239,4841 (1988): 790-1. doi: https://doi.org/10.1126/science.239.4841.790
Wong DF, Gjedde A, Wagner HM, Dannals RF, Links JM, Tune LE, Pearlson GD. In reply: elevated d2 dopamine receptors in drug-naive schizophrenics. Science. 1988 Feb 12;239(4841):790-1. doi: 10.1126/science.239.4841.790. PMID: 17832943.
Copy Download .nbib Format: NLM
A review on the use of chelating agents as an alternative to promote photo-Fenton at neutral pH: Current trends, knowledge gap and future studies.

The Science of the total environment

Ahile UJ, Wuana RA, Itodo AU, Sha'Ato R, Dantas RF.
PMID: 31923651
Sci Total Environ. 2020 Mar 25;710:134872. doi: 10.1016/j.scitotenv.2019.134872. Epub 2019 Dec 10.

In this review, we have critically examined the alternatives to conventional photo-Fenton process such as the strategies to perform it in circumneutral pH in the so-called photo-Fenton like process. They include iron chelation, iron replacement with another metal and...

Cite
Ahile UJ, Wuana RA, Itodo AU, et al. A review on the use of chelating agents as an alternative to promote photo-Fenton at neutral pH: Current trends, knowledge gap and future studies. Sci Total Environ. 2019;710:134872doi: 10.1016/j.scitotenv.2019.134872.
Ahile, U. J., Wuana, R. A., Itodo, A. U., Sha'Ato, R., & Dantas, R. F. (2020). A review on the use of chelating agents as an alternative to promote photo-Fenton at neutral pH: Current trends, knowledge gap and future studies. The Science of the total environment, 710134872. https://doi.org/10.1016/j.scitotenv.2019.134872
Ahile, Ungwanen J, et al. "A review on the use of chelating agents as an alternative to promote photo-Fenton at neutral pH: Current trends, knowledge gap and future studies." The Science of the total environment vol. 710 (2020): 134872. doi: https://doi.org/10.1016/j.scitotenv.2019.134872
Ahile UJ, Wuana RA, Itodo AU, Sha'Ato R, Dantas RF. A review on the use of chelating agents as an alternative to promote photo-Fenton at neutral pH: Current trends, knowledge gap and future studies. Sci Total Environ. 2020 Mar 25;710:134872. doi: 10.1016/j.scitotenv.2019.134872. Epub 2019 Dec 10. PMID: 31923651.
Copy Download .nbib Format: NLM
PET imaging of soluble epoxide hydrolase in non-human primate brain with [.

EJNMMI research

Du Y, Minn I, Foss C, Lesniak WG, Hu F, Dannals RF, Pomper MG, Horti AG.
PMID: 32572592
EJNMMI Res. 2020 Jun 22;10(1):67. doi: 10.1186/s13550-020-00657-7.

PURPOSE: Soluble epoxide hydrolase (sEH) is a promising candidate positron emission tomography (PET) imaging biomarker altered in various disorders, including vascular cognitive impairment (VCI), Alzheimer's disease (AD), Parkinson's disease (PD), stroke, and depression, known to regulate levels of epoxyeicosatrienoic...

Cite
Du Y, Minn I, Foss C, et al. PET imaging of soluble epoxide hydrolase in non-human primate brain with [. EJNMMI Res. 2020;10(1):67doi: 10.1186/s13550-020-00657-7.
Du, Y., Minn, I., Foss, C., Lesniak, W. G., Hu, F., Dannals, R. F., Pomper, M. G., & Horti, A. G. (2020). PET imaging of soluble epoxide hydrolase in non-human primate brain with [. EJNMMI research, 10(1), 67. https://doi.org/10.1186/s13550-020-00657-7
Du, Yong, et al. "PET imaging of soluble epoxide hydrolase in non-human primate brain with [." EJNMMI research vol. 10,1 (2020): 67. doi: https://doi.org/10.1186/s13550-020-00657-7
Du Y, Minn I, Foss C, Lesniak WG, Hu F, Dannals RF, Pomper MG, Horti AG. PET imaging of soluble epoxide hydrolase in non-human primate brain with [. EJNMMI Res. 2020 Jun 22;10(1):67. doi: 10.1186/s13550-020-00657-7. PMID: 32572592; PMCID: PMC7310027.
Copy Download .nbib Format: NLM
Natural products targeting into cancer hallmarks: An update on caffeine, theobromine, and (+)-catechin.

Critical reviews in food science and nutrition

Cadoná FC, Dantas RF, de Mello GH, Silva-Jr FP.
PMID: 33890518
Crit Rev Food Sci Nutr. 2021 Apr 23;1-20. doi: 10.1080/10408398.2021.1913091. Epub 2021 Apr 23.

Natural products have been studied to reveal new therapies against human dysfunctions since they present several medicinal properties. Caffeine, theobromine and (+)-catechin are remarkable natural agents in the class of methylxanthines and flavonoids. These bioactive molecules have several biological...

Cite
Cadoná FC, Dantas RF, de Mello GH, et al. Natural products targeting into cancer hallmarks: An update on caffeine, theobromine, and (+)-catechin. Crit Rev Food Sci Nutr. 2021;1-20doi: 10.1080/10408398.2021.1913091.
Cadoná, F. C., Dantas, R. F., de Mello, G. H., & Silva-Jr, F. P. (2021). Natural products targeting into cancer hallmarks: An update on caffeine, theobromine, and (+)-catechin. Critical reviews in food science and nutrition, 1-20. https://doi.org/10.1080/10408398.2021.1913091
Cadoná, Francine C, et al. "Natural products targeting into cancer hallmarks: An update on caffeine, theobromine, and (+)-catechin." Critical reviews in food science and nutrition vol. (2021): 1-20. doi: https://doi.org/10.1080/10408398.2021.1913091
Cadoná FC, Dantas RF, de Mello GH, Silva-Jr FP. Natural products targeting into cancer hallmarks: An update on caffeine, theobromine, and (+)-catechin. Crit Rev Food Sci Nutr. 2021 Apr 23;1-20. doi: 10.1080/10408398.2021.1913091. Epub 2021 Apr 23. PMID: 33890518.
Copy Download .nbib Format: NLM
Dynamic PET-facilitated modeling and high-dose rifampin regimens for .

Science translational medicine

Gordon O, Lee DE, Liu B, Langevin B, Ordonez AA, Dikeman DA, Shafiq B, Thompson JM, Sponseller PD, Flavahan K, Lodge MA, Rowe SP, Dannals RF, Ruiz-Bedoya CA, Read TD, Peloquin CA, Archer NK, Miller LS, Davis KM, Gobburu JVS, Jain SK.
PMID: 34851697
Sci Transl Med. 2021 Dec;13(622):eabl6851. doi: 10.1126/scitranslmed.abl6851. Epub 2021 Dec 01.

[Figure: see text].

Cite
Gordon O, Lee DE, Liu B, et al. Dynamic PET-facilitated modeling and high-dose rifampin regimens for . Sci Transl Med. 2021;13(622):eabl6851doi: 10.1126/scitranslmed.abl6851.
Gordon, O., Lee, D. E., Liu, B., Langevin, B., Ordonez, A. A., Dikeman, D. A., Shafiq, B., Thompson, J. M., Sponseller, P. D., Flavahan, K., Lodge, M. A., Rowe, S. P., Dannals, R. F., Ruiz-Bedoya, C. A., Read, T. D., Peloquin, C. A., Archer, N. K., Miller, L. S., Davis, K. M., Gobburu, J. V. S., & Jain, S. K. (2021). Dynamic PET-facilitated modeling and high-dose rifampin regimens for . Science translational medicine, 13(622), eabl6851. https://doi.org/10.1126/scitranslmed.abl6851
Gordon, Oren, et al. "Dynamic PET-facilitated modeling and high-dose rifampin regimens for ." Science translational medicine vol. 13,622 (2021): eabl6851. doi: https://doi.org/10.1126/scitranslmed.abl6851
Gordon O, Lee DE, Liu B, Langevin B, Ordonez AA, Dikeman DA, Shafiq B, Thompson JM, Sponseller PD, Flavahan K, Lodge MA, Rowe SP, Dannals RF, Ruiz-Bedoya CA, Read TD, Peloquin CA, Archer NK, Miller LS, Davis KM, Gobburu JVS, Jain SK. Dynamic PET-facilitated modeling and high-dose rifampin regimens for . Sci Transl Med. 2021 Dec;13(622):eabl6851. doi: 10.1126/scitranslmed.abl6851. Epub 2021 Dec 01. PMID: 34851697; PMCID: PMC8693472.
Copy Download .nbib Format: NLM
Dynamic PET-facilitated modeling and high-dose rifampin regimens for .

Science translational medicine

Gordon O, Lee DE, Liu B, Langevin B, Ordonez AA, Dikeman DA, Shafiq B, Thompson JM, Sponseller PD, Flavahan K, Lodge MA, Rowe SP, Dannals RF, Ruiz-Bedoya CA, Read TD, Peloquin CA, Archer NK, Miller LS, Davis KM, Gobburu JVS, Jain SK.
PMID: 34851697
Sci Transl Med. 2021 Dec;13(622):eabl6851. doi: 10.1126/scitranslmed.abl6851. Epub 2021 Dec 01.

[Figure: see text].

Cite
Gordon O, Lee DE, Liu B, et al. Dynamic PET-facilitated modeling and high-dose rifampin regimens for . Sci Transl Med. 2021;13(622):eabl6851doi: 10.1126/scitranslmed.abl6851.
Gordon, O., Lee, D. E., Liu, B., Langevin, B., Ordonez, A. A., Dikeman, D. A., Shafiq, B., Thompson, J. M., Sponseller, P. D., Flavahan, K., Lodge, M. A., Rowe, S. P., Dannals, R. F., Ruiz-Bedoya, C. A., Read, T. D., Peloquin, C. A., Archer, N. K., Miller, L. S., Davis, K. M., Gobburu, J. V. S., & Jain, S. K. (2021). Dynamic PET-facilitated modeling and high-dose rifampin regimens for . Science translational medicine, 13(622), eabl6851. https://doi.org/10.1126/scitranslmed.abl6851
Gordon, Oren, et al. "Dynamic PET-facilitated modeling and high-dose rifampin regimens for ." Science translational medicine vol. 13,622 (2021): eabl6851. doi: https://doi.org/10.1126/scitranslmed.abl6851
Gordon O, Lee DE, Liu B, Langevin B, Ordonez AA, Dikeman DA, Shafiq B, Thompson JM, Sponseller PD, Flavahan K, Lodge MA, Rowe SP, Dannals RF, Ruiz-Bedoya CA, Read TD, Peloquin CA, Archer NK, Miller LS, Davis KM, Gobburu JVS, Jain SK. Dynamic PET-facilitated modeling and high-dose rifampin regimens for . Sci Transl Med. 2021 Dec;13(622):eabl6851. doi: 10.1126/scitranslmed.abl6851. Epub 2021 Dec 01. PMID: 34851697; PMCID: PMC8693472.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 25 entries